Influences on therapists decisions for neuroleptic treatment in schizophrenia: The role of characteristics of the patient and the physician

Pharmacopsychiatry

Volumn 45, Issue 7, 2012, Pages 261-268

  Franz, M ^a,b   Ranger, J ^a   Hanewald, B ^a   Gallhofer, B ^a   Lay, B ^c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Vitos Kurhessen Clinic for Psychiatry and Psychotherapy   (Germany)

^c UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

Author keywords

medical decision making; neuroleptic treatment; schizophrenia; schizophrenia treatment

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; CLINICAL DECISION MAKING; CLINICAL PRACTICE; EDUCATIONAL STATUS; FEMALE; GERMANY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATION; PATIENT COMPLIANCE; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SOCIAL INTERACTION; SOCIAL STATUS; VIGNETTE; AGE; DECISION MAKING; EMPLOYMENT; HEALTH CARE SURVEY; MENTAL HOSPITAL; METHODOLOGY; PRIVATE PRACTICE; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; SEXUAL DEVELOPMENT; STATISTICS;

AGE FACTORS; ANTIPSYCHOTIC AGENTS; DECISION MAKING; EDUCATIONAL STATUS; EMPLOYMENT; GERMANY; HEALTH CARE SURVEYS; HOSPITALS, PSYCHIATRIC; HUMANS; MEDICATION ADHERENCE; PHYSICIAN'S PRACTICE PATTERNS; PRIVATE PRACTICE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX CHARACTERISTICS;

EID: 84869501571     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0032-1312609     Document Type: Review

References (45)

1. McEvoy J., Scheifler P., Frances A. The expert consensus guideline series: Treatment of schizophrenia 1999. J Clin Psychiatry. 1999; 60 9 34
2. Kane J. M., Leucht S., Carpenter D. et al. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry: 2003; 64 5 19
3. American Psychiatric Association Practice guideline for the treatment of patients with schizophrenia. Washington American Psychiatric Publishing: 2004
4. Leucht S., Heres S., Kissling W. et al. Evidence-based pharmacotherapy of schizophrenia. Int J Neuropsychopharmacol: 2011; 14 269 284
5. Leslie D. L., Rosenheck R. The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophrenia. J Nervous Mental Dis: 2001; 189 377 383
6. Mamdani M., Tu K., Austin P. et al. Influence of socioeconomic status on drug Selection for the elderly in Canada. Ann Pharmacother: 2002; 36 804 808
7. Ren X. S., Kazis L. E., Lee A. F. et al. Patient characteristics and prescription patterns of atypical antipsychotics among patients with schizophrenia. J Clin Pharm Therap: 2002; 27 441 451
8. Copeland L., Zeber J., Valenstein M. et al. Racial disparity in the use of atypical antipsychotic medications among veterans. Am J Psychiatry: 2003; 160 1817 1822
9. Hamann J., Ruppert A., Auby P. et al. Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription database. Int Clin Psychopharmacol: 2003; 18 237 242
10. Chong M. Y., Tan C. H., Fujii S. et al. Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change. Psychiatry Clin Neurosci: 2004; 58 61 67
11. Gaebel W., Riesbeck M., Janssen B. et al. Atypical and typical neuroleptics in acute schizophrenia and related delusional disorders. Drug choice, switching and outcome under naturalistic treatment conditions. Eur Arch Psychiatry Clin Neurosc: 2004; 253 175 184
12. Magliano L., Fiorillo A., Guarneri M. et al. Prescription of psychotropic drugs to patients with schizophrenia: an Italian national survey. Eur J Clin Pharmacol: 2004; 60 513 522
13. Hoblyn J., Noda A., Yesavage J. A. et al. Factors in choosing atypical antipsychotics: toward understanding the bases of physicians prescribing decisions. J Psychiatric Res: 2006; 40 160 166
14. Valenstein M., Copeland L., Owen R. et al. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia. J Clin Psychiatry: 2001; 62 545 551
15. Sim K., Su A., Ungvari G. et al. Depot antipsychotic use in schizophrenia: an East Asian perspective. Human Psychopharmacol: 2004; 19 103 109
16. Shi L., Ascher-Svanum H., Zhu B. et al. Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia. Psychiatric Services: 2007; 58 482 488
17. Mahadun P., Marshall M. Insight and treatment attitude in schizophrenia: comparison of patients on depot and atypical antipsychotics. Psychiatrist: 2008; 32 53 56
18. Vehof J., Postma M. J., Bruggeman R. et al. Predictors for starting depot administration of risperidone in chronic users of antipsychotics. J Clin Psychopharmacol: 2008; 28 625 630
19. West J. C., Marcus S. C., Wilk J. et al. Use of depot antipsychotic medications for medication nonadherence in schizophrenia. Schizophr Bull: 2008; 34 995 1001
20. Ascher-Svanum H., Peng X., Faries D. et al. Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients. BMC Psychiatry: 2009; 9 46 54
21. Barnes T., Shingleton-Smith A., Paton C. Antipsychotic long-acting injections: prescribing practice in the UK. Br J Psychiatry: 2009; 195 37 42
22. Citrome L., Jaffe A., Levine J. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities. Schizophr Res: 2010; 119 153 159
23. Kelin K., Brnabic A., Newton R. et al. Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherence. Patient Preference Adherence: 2010; 4 301 311
24. Eisenberg J. M. Sociological influences on decison-making by clinicians. Ann Intern Med: 1979; 90 957 964
25. Denig P., Haaijer-Ruskamp F. M. Therapeutic decision making of physicians. Pharmacy World & Science: 1992; 14 9 15
26. Bradley C. P. Decision making and prescribing patterns - a literature review. Family Practice: 1991; 8 276 287
27. Figueras A. The use of drugs is not as rational as we believe, but it cant be! The emotional roots of prescribing. Eur J Clin Pharmacol: 2011; 67 433 435
28. American Psychological Association Task Force on Socioeconomic Status Report of the APA task force on socioeconomic status. Washington American Psychological Association: 2007
29. Scott A., Shiell A., King M. Is general practitioner decision making associated with patient socioeconomic status? Soc Sci Med: 1996; 42 35 46
30. Wang P. S., West J. C., Tanielian T. et al. Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia and other psychotic disorders. Schizophr Bull: 2000; 26 451 457
31. Clark J. A., Potter D. A., McKinlay J. B. Bringing social structure back into clinical decision making. Soc Sci Med: 1991; 32 853 866
32. DGPPN Praxisleitlinien in Psychiatrie und Psychotherapie. Band 1: Behandlungsleitlinien Schizophrenie. Darmstadt Steinkopff: 1998
33. Waddell L., Taylor M. Attitudes of patients and mental health staff to antipsychotic long-acting injections: systematic review. Br J Psychiatry: 2009; 52 S43 S50
34. Koch G., Landis J., Freeman J. et al. A general methodology for the analysis of experiments with repeated measurement of categorical data. Biometrics: 1977; 33 133 158
35. SAS Institute Inc SAS/STAT Users Guide, Version 8. Cary, NC SAS Institute Inc: 1999
36. Agresti A., Booth J. G., Hobert J. P. et al. Random-effects modeling of categorical response data. Sociolog Methodol: 2000; 30 27 80
37. Train K. Discrete choice methods with simulation. Cambridge: University Press. 2003
38. Raudenbush S. W., Bryk A. S., Congdon R. HLM 6 for Windows [Computer software]. Lincolnwood, IL Scientific Software International
39. Thompson K., Kulkarni J., Sergejew A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res: 2000; 42 241 247
40. Tavacar R., Dernovsek M. Z., Zvan V. Choosing antipsychotic maintenance therapy: a naturalistic study. Pharmacopsychiatry: 2000; 33 66 71
41. Kuno E., Rothbard A. Racial disparities in antipsychotic prescription patterns for patients with schizophrenia. Am J Psychiatry: 2002; 159 567 572
42. Barbui C., Danese A., Guaiana G. et al. Prescribing second-generation antipsychotics and the evolving standard of care in Italy. Pharmacopsychiatry: 2002; 35 239 243
43. Jones T. V., Gerrity M. S., Earp J. Written case simulations: do they predict physicians behavior? J Clin Epidemiol: 1990; 43 805 815
44. Morell D. C., Roland M. O. Analysis of referral behaviour: responses to simulated case histories may not reflect real clinical behaviour. Br J Gen Pract: 1990; 40 182 185
45. Tamayo-Sarver J. H., Dawson N. V., Hinze S. W. et al. The effect of race ethnicity and desirable social characteristics on physicians decision to prescribe opioide analgesics. Academic Emerg Med: 2003; 10 1239 1248